Pilot Test of a Community-based Buprenorphine Treatment Intervention

Not Applicable

Completed

• Conditions: Injection Drug Use; Opioid Dependence
• Interventions: Behavioral: Community-based buprenorphine treatment (CBBT) intervention

• Registration Number: NCT01761110
• Lead Sponsor: Albert Einstein College of Medicine

Brief Summary

The main goal of this study is to pilot test the community-based buprenorphine treatment (CBBT) intervention, examining buprenorphine treatment initiation, opioid use, and HIV risk behaviors. Two groups of participants will be followed for 60 days, with 3 research visits. One group will be enrolled prior to the CBBT intervention (pre-intervention), and one group after the CBBT intervention (post-intervention). Data sources will include questionnaires, urine toxicology tests, and medical record data. Investigators hypothesize that compared to the participants in the pre-intervention group, participants in the post-intervention group will be more likely to initiate buprenorphine treatment, reduce opioid use, and reduce high-risk HIV risk behaviors.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-12
• Study First Submitted: 2013-01-02
• Study First Submitted QC: 2013-01-02
• Study First Posted: 2013-01-04
• Primary Completion: 2014-02
• Study Completion: 2014-02
• Status Verified: 2018-04
• Last Update Submitted: 2018-04-19
• Last Update Posted: 2018-04-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 77

Inclusion Criteria

• at least 18 years old
• English or Spanish fluency
• ever injected drugs
• not receiving buprenorphine treatment (no prescribed buprenorphine in the previous 6 months)
• clients of our collaborating community-based organization
• interested in buprenorphine treatment

Exclusion Criteria

• pregnant
• taking more than 60mg of methadone daily in the previous 30 days

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Post-intervention	Community-based buprenorphine treatment (CBBT) intervention	Participants will be enrolled after implementing the community-based buprenorphine treatment (CBBT) intervention

Primary Outcome Measures

Name	Time	Method
initiation of buprenorphine treatment	60 days	Medical record information will be extracted to determine initiation of buprenorphine treatment, which will be defined as a visit with a medical provider in which buprenorphine is prescribed.

Secondary Outcome Measures

Name	Time	Method
opioid use	60 days	Opioid use will be determined via self-report using the Addiction Severity Index and via urine specimens (e.g., urine toxicology testing).

Trial Locations

Locations (1)

Washington Heights Corner Project; 🇺🇸 New York, New York, United States